EBO
EBOS FPO NZ [EBO]
Healthcare · ASX Small Cap
$19.1800 -0.9%
Updated 7 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -2First seen: 2026-03-06
Score Breakdown
Technical54
Catalyst50
Sentiment50
Fundamental96
Momentum36
Risk Gate47
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Near support level (potential bounce)
- Cash positive / operating cashflow positive
- Low P/S ratio (0.3x)
- Moderate revenue growth (+13%)
- Piotroski F-Score strong (8/9, low-confidence approx)
- EPS estimates revised upward (+10pts)
- Near 52-week low (1% of range)
- CANSLIM C: Positive EPS growth (13% QoQ)
- CANSLIM I: Institutional ownership (26%)
- Poor risk-adjusted momentum (Sharpe -2.4)
- RBA hiking (-3pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-38%)
- Volume-weighted momentum negative (-0.47%/day)
- Overseas neutral (-3pts, S&P500 neutral, VIX 27)
Recent Catalysts
NONE S&P DJI Announces March 2026 Quarterly Rebalance
NONE NZ Ongoing Disclosure Notice
NONE ASX Appendix 3Y
Recent ASX Announcements
| 2026-03-06 | S&P DJI Announces March 2026 Quarterly Rebalance PRICE SENSITIVE |
| 2026-03-03 | NZ Ongoing Disclosure Notice |
| 2026-03-03 | ASX Appendix 3Y |
| 2026-02-24 | Dividend/Distribution - EBO |
| 2026-02-24 | Shareholders Letter PRICE SENSITIVE |
Key Metrics
$4.0B
Market Cap
105K
Avg Volume
1.9x
Vol Ratio
$19.10 — $38.23
52-Week Range
0.5%
Short Interest
N/A
Cash Runway
9.0%
ROE
1.8%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | weak | EPS Growth: 13% |
| A | Annual Earnings | neutral | CAGR: 1% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 94% |
| L | Leader vs Laggard | laggard | RS: -11 |
| I | Institutional Sponsorship | pass | Inst: 26% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #63 of 122 · Sector avg: 43
View all Healthcare signals →